Endoscopic Retrograde Cholangiopancreatography Market Players:
- Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Cook Medical LLC
- Olympus Corporation
- Conmed Corporation
- Medtronic plc
- Fujifilm Holdings Corporation
- ERBE Elektromedizin GmbH
- Steris plc
- Karl Storz GmbH & Co. KG
- Ethicon Endo-Surgery, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of endoscopic retrograde cholangiopancreatography is estimated at USD 2.57 billion.
The global endoscopic retrograde cholangiopancreatography market size crossed USD 2.38 billion in 2025 and is likely to register a CAGR of over 9.1%, exceeding USD 5.69 billion revenue by 2035.
The Asia Pacific endoscopic retrograde cholangiopancreatography market is forecasted to hold a 35% share by 2035, driven by increasing prevalence of pancreatic and biliary diseases.
Key players in the market include Boston Scientific Corporation, Cook Medical LLC, Olympus Corporation, Conmed Corporation, Medtronic plc, Fujifilm Holdings Corporation, ERBE Elektromedizin GmbH, Steris plc, Karl Storz GmbH & Co. KG, Ethicon Endo-Surgery, Inc.
